Alphavirus replicon particles expressing the two major envelope proteins of equine arteritis virus induce high level protection against challenge with virulent virus in vaccinated horses

Author： Balasuriya U.B.R.   Heidner H.W.   Davis N.L.   Wagner H.M.   Hullinger P.J.   Hedges J.F.   Williams J.C.   Johnston R.E.   David Wilson W.   Liu I.K.   James MacLachlan N.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.20, Iss.11, 2002-02, pp. : 1609-1617

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chimeric (marker) C-strain viruses induce clinical protection against virulent classical swine fever virus (CSFV) and reduce transmission of CSFV between vaccinated pigs

By de Smit A.J.   Bouma A.   van Gennip H.G.P.   de Kluijver E.P.   Moormann R.J.M.  

Vaccine, Vol. 19, Iss. 11, 2001-12 ,pp. : 1467-1476

Elsevier

Access to resources Recommend Favorite

TC-83 vaccine protects against airborne or subcutaneous challenge with heterologous mouse-virulent strains of Venezuelan equine encephalitis virus

By Phillpotts R.J.   Wright A.J.  

Vaccine, Vol. 17, Iss. 7, 1999-02 ,pp. : 982-988

Elsevier

Access to resources Recommend Favorite

Rinderpest virus (RPV) ISCOM vaccine induces protection in cattle against virulent RPV challenge

By Kamata H.   Ohishi K.   Hulskotte E.   Osterhaus A.D.M.E.   Inui K.   Shaila M.S.   Yamanouchi K.   Barrett T.  

Vaccine, Vol. 19, Iss. 25, 2001-05 ,pp. : 3355-3359

Elsevier

Access to resources Recommend Favorite

DNA vaccination of neonate piglets in the face of maternal immunity induces humoral memory and protection against a virulent pseudorabies virus challenge

By Fischer L.   Barzu S.   Andreoni C.   Buisson N.   Brun A.   Audonnet J.-C.  

Vaccine, Vol. 21, Iss. 15, 2003-04 ,pp. : 1732-1741

Elsevier

Access to resources Recommend Favorite

Feline immunodeficiency virus subunit vaccines that induce virus neutralising antibodies but no protection against challenge infection

By Huisman W.   Karlas J.A.   Siebelink K.H.J.   Huisman R.C.   de Ronde A.   Francis M.J.   Rimmelzwaan G.F.   Osterhaus A.D.M.E.  

Vaccine, Vol. 16, Iss. 2, 1998-01 ,pp. : 181-187

Elsevier

Access to resources Recommend Favorite